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AbstrACt
Objective Changes in the gut microbiota are increasingly 
recognised to be involved in many diseases. This 
ecosystem is known to be shaped by many factors, 
including climate, geography, host nutrition, lifestyle and 
medication. Thus, knowledge of varying populations with 
different habits is important for a better understanding of 
the microbiome.
Design We therefore conducted a metagenomic 
analysis of intestinal microbiota from Kazakh 
donors, recruiting 84 subjects, including male and 
female healthy subjects and metabolic syndrome 
(MetS) patients aged 25–75 years, from the Kazakh 
administrative centre, Astana. We characterise and 
describe these microbiomes, the first deep-sequencing 
cohort from Central Asia, in comparison with a global 
dataset (832 individuals from five countries on 
three continents), and explore correlations between 
microbiota, clinical and laboratory parameters as 
well as with nutritional data from Food Frequency 
Questionnaires.
results We observe that Kazakh microbiomes are 
relatively different from both European and East Asian 
counterparts, though similar to other Central Asian 
microbiomes, with the most striking difference being 
significantly more samples falling within the Prevotella-
rich enterotype, potentially reflecting regional diet and 
lifestyle. We show that this enterotype designation 
remains stable within an individual over time in 82% of 
cases. We further observe gut microbiome features that 
distinguish MetS patients from controls (eg, significantly 
reduced Firmicutes to Bacteroidetes ratio, Bifidobacteria 
and Subdoligranulum, alongside increased Prevotella), 
though these overlap little with previously published 
reports and thus may reflect idiosyncrasies of the 
present cohort.
Conclusion Taken together, this exploratory study 
describes gut microbiome data from an understudied 
population, providing a starting point for further 
comparative work on biogeography and research on 
widespread diseases.
trial registration number ISRCTN37346212; Post-
results. 
IntrODuCtIOn 
Microbial contributions to human health, 
as currently understood, involve digestion, 
metabolism of endogenous and exogenous 
compounds, modulation of immune defense 
mechanisms and hindering colonisation of 
the gastrointestinal tract by (competitor) 
pathogenic microorganisms.1 Microbial cells 
produce many of the necessary enzymes for 
digesting carbohydrates and proteins in the 
colon, which the human host cells cannot.2 
Diet has strong influences on microbial 
composition and diversity,3 4 alongside factors 
such as climate and geography surrounding 
the human host5 or the genetics of that host. 
strengths and limitations of this study
 ► These are the first high-resolution data on the gut 
microbiome of a Central Asian population. We show 
that these microbiomes are similar to those else-
where while still exhibiting regional idiosyncrasy, in-
cluding with regards to locally unique gene variants.
 ► Kazakh samples are significantly and strongly 
skewed towards a Prevotella-rich enterotype, a 
skew that holds for both autumn and winter sam-
ples, both MetS cases and controls, and both place-
bo and synbiotic study subjects.
 ► We are able to demonstrate significant associations 
between dietary factors and the microbiome in a 
large cohort quantified at high resolution.
 ► Participants are all volunteers from the capital city of 
Astana, all governmental employees and predomi-
nantly female. As such, they are not a representative 
sample of the Kazakh population as a whole in all 
regards.
 ► Due to probiotic genomes not having been se-
quenced, we cannot yet trace carriage of these 
strains at high resolution, and as such, cannot ev-
idence that the effect of the synbiotic occurs via mi-
crobiome changes as opposed to direct or indirect 
effects on the host.
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All these factors could potentially affect the pathogen-
esis and course of various diseases, such as the metabolic 
syndrome (MetS), characterised by obesity, hypertension, 
high blood glucose and high levels of hard digestible fatty 
acids in the blood.6 MetS is further strongly comorbid 
with more severe metabolic and cardiovascular diseases 
and is growing in prevalence worldwide.7 According to 
epidemiological studies from 2016, the overall preva-
lence of type 2 diabetes (T2D) in Kazakhstan is 12.5%,8 a 
number that is increasing over time.8 
Thus, an understanding of the gut microbiome and 
its role in aetiopathogenesis becomes crucial, with a 
perspective towards personal diet control to more effi-
ciently improve health.4 Moreover, recognising that the 
extent of global variability in gut microbiome composi-
tion and reactivity remains unknown,5 particularly in 
populations where traditional lifestyle practices may play 
a strong role, we here present the first metagenomic anal-
ysis of gut microbiota from Kazakh individuals, recruited 
from the administrative centre of Astana, comprising 84 
male or female healthy subjects and MetS patients aged 
between 29 years and 75 years. We analyse these data in a 
global context and evaluate how the Kazakh microbiomes 
correlate with clinical and lifestyle parameters as well as 
the influence of the NAR synbiotic, derived from tradi-
tional Kazakh medicinal foods, on the gut microbiome. 
Thus, in addition to describing an understudied popula-
tion, we also aimed to provide further knowledge into a 
pathology common to this population8 and into an inter-
vention that could possibly contribute to its treatment.
MethODs
Cohort
Eighty-four healthy and non-healthy male and female 
individuals aged 25–75 years were recruited in Astana, at 
the administrative centre of Kazakhstan. Ethnic structure 
is diverse and includes Kazakh, Russian, Tatars, Ukrai-
nians, Uzbeks and Germans. The case group included 
participants with overweight, diagnosed diabetes and/or 
hypertension, thus presenting the MetS. Exclusion criteria 
included any evidence of taking antibiotics for 3 months 
or less prior to sampling. The consent documents were 
signed by all participants before faecal sample collection. 
Before the start of the study, all patients were examined 
comprehensively, including clinical and laboratory exam-
ination and survey. Clinical and laboratory data collected 
include anthropometrics, cardiovascular status (systolic 
and diastolic blood pressure and heart rate), blood 
lipid profile, levels of circulating inflammatory markers, 
immunologic status and the results of general inspection 
analysis of faeces (coprogram), as well as records of stool 
consistency and frequency, together with a questionnaire 
about habitual food consumption along with a consent 
form. The questionnaire included an assessment of the 
patient’s health, familial anamnesis, standard metadata as 
per the MyMicrobes protocol (http:// my. microbes. eu/) 
and a Food Frequency Questionnaire (FFQ) section. All 
physical measurements were made by a trained medical 
professional and include height, weight, waist and hip 
circumference, blood pressure and heart rate.
Patient and public involvement
Participants were recruited from attendees of the Medical 
Centre Hospital of President’s Affairs Administration 
of the Republic of Kazakhstan. Hospital employees 
conducted recruitment and instructed the participants 
both on the analysis and the correct procedure for collec-
tion and delivery of the stool sample and use of the synbi-
otic/placebo. Participants were not otherwise directly 
involved in either study design or participant recruit-
ment. At the stage of recruiting, all patients received a 
complete set of information about the tested synbiotic, 
the research goals and all planned clinical and laboratory 
investigations. The patients independently and volun-
tarily decided to participate in the study. All patients were 
informed that they have the right to refuse further partic-
ipation at any stage and confirmed their participation in 
the study by signing this informed consent. The results of 
the research will be disseminated to the public through 
publications in scientific journals and proceedings of 
profile conferences but not directly communicated to 
the individual participants beyond this. The patients were 
randomised to synbiotic or placebo using to the electronic 
database of the medical centre, without their health state 
playing any role in this randomisation. No evaluation of 
the effect of the intervention was communicated directly 
to the (anonymised for integrity purposes) participants.
sample collection
A stool sampling kit consisting of a sample collection tube, 
cotton swabs and sterile tissue papers was given to each 
subject. Human faecal samples were collected and frozen 
immediately. The collection procedure was repeated 
again with an average interval between samplings of 
90±5 days. Faecal samples collected were placed at −20°C 
immediately after they were produced and at −80°C within 
24 hours. All samples were maintained at −80°C until they 
were used for metagenomic studies.
sample processing and sequencing
DNA isolation from faecal samples
Total DNA was extracted from all faecal samples (two 
samples/individual) using an adapted G’NOME kit (BIO 
101) protocol as described in Zeller et al.9
Library preparation and metagenomic sequencing
Samples were sequenced at the EMBL GeneCore facility 
using an Illumina HiSeq 2500. On average 2.7±1.1 Gbp of 
100 base pairs (bp) paired-end shotgun sequencing reads 
was generated for each sample.
Data processing
Reads were processed using the MOCAT pipeline10 to 
determine bacterial species abundance under the metag-
enomic Operational Taxonomic Unit (mOTU) frame-
work11 and mapping reads to a previously described gut 
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microbial gene catalogue12 in order to assess functional 
capacity. Furthermore, community ecological indices, 
including taxonomic richness and evenness as well as 
Shannon diversity, were determined based on rarefaction 
analysis of the mOTU data (following the procedure in 
Qin et al).13
Data analysis
Computer analysis thus provides the following results: 
taxonomic composition of samples with respect to 
metagenome-derived (reference-free) taxonomic units 
(mOTUs11); taxonomic composition of samples with 
respect to a reference database of known microbial 
genomes14 median abundance across each such gene 
group here used as a measure of abundance of each 
metagenomic species; taxonomic distance between 
samples (Bray-Curtis and log-transformed Euclidean 
distances between mOTU profiles); ecological diversity 
of samples (derived from subsampling of mOTU abun-
dances); gene richness of samples (derived from subsam-
pling hits to the 10M reference gene catalogue previously 
published12; enterotypes of samples (derived clustering 
together with samples used originally to identify entero-
types15; functional profiles of samples with respect to 
Kyoto Encyclopedia of Genes and Genomes (KEGG) 
modules and pathways (based on mapping of reads to 
the 263 sample reference gene catalogue previously 
described, annotated based on homology to KEGG anno-
tated genes16; and functional profiles of samples with 
respect to antibiotic resistances (based on mapping of 
reads to the 10M gene catalogue previously described, 
annotated based on homology to antibiotic resistance 
genes in the ResFams database.17
Data availability
Samples have been deposited to the ENA archive under 
accession PRJEB17632.
results
Cohort description and data collection
In total, 84 participants were enrolled in the study in 
2015. These involved voluntary participants from two 
categories: one group diagnosed with MetS (n=58), and 
a second group of healthy controls (n=26). Antibiotic 
use in the last 3 months was an exclusion criterion. Stool 
samples were collected twice: once in summer (August) 
and once in winter (January) (168 samples in total). 
The current setup thus provides multiple dimensions of 
potential contrasts: summer/winter (with corresponding 
dietary changes), MetS patients versus healthy subjects 
and dietary effects. Additionally, all participants following 
autumn sample collection began a minor diet change: 
taking daily either synbiotic (ie, combining prebiotic 
and probiotic components) yoghurt or placebo as part 
of the study. The placebo was an inactive milk fermenta-
tion, whereas the synbiotic contains six probiotic strains, 
as well as the prebiotics fish collagen and pectin (data not 
shown). Figure 1 highlights the design of the study.
The cohort by design is relatively homogeneous for life-
style and socioeconomic status, as recruitment of partic-
ipants was carried out in an Astana city hospital, which 
specifically treats employees of governmental organisa-
tions. The majority of participants moved to Astana within 
the last two decades, in the course of its establishment 
as an administrative centre. An overview of basic demo-
graphic data for the 84 participants is provided in table 1. 
Participants’ ages ranged between 29 years and 75 years, 
with an average of 50.39 years (median 50 years). A slight 
majority of participants (54/84) were female. Additional 
data collected includes anamnesis of diseases other than 
the MetS, as well as anamnesis of family morbidity (specif-
ically, morbidity of siblings or parents). To assess whether 
there is structure in these disease histories, we carried out 
a hierarchical clustering (Ward clustering on a binary 
distance measure) on these variables, resolving two major 
clusters of comorbidity visible in the cohort, as seen in 
online supplementary figure 1. Under this measure, most 
familial comorbidities cluster together with MetS status 
and variables denoting severity of any disease sufficient to 
limit daily activity, whereas most other diagnoses present 
Figure 1 Study design. This scheme shows the design of 
the study and the setup of the cohort. Eighty-four subjects 
(healthy or with MetS) were sampled twice, in summer 
and in winter, with half receiving placebo and half the NAR 
synbiotic. This setup allows multiple contrasts: seasonal 
variation, MetS cases versus control and differential effects of 
placebo versus synbiotics. In addition, Kazakh samples were 
placed into the a global context by comparison with other 
samples. MetS, metabolic syndrome.
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in the cohort are scattered outside this cluster. Further-
more, 55% of MetS patients have anamnesis of T2D, 
hypertension, myocardial infarction or stroke in either 
parents or siblings, consistent with shared heredity of 
T2D with cardiovascular disease.18
the composition of the gut microbiota of individuals from 
Kazakhstan
Comparing the composition of the Kazakh samples to 
that of other available datasets (US Human Microbiome 
Project data19), Spanish and Danish MetaHIT samples,20 
Swedish21 and Chinese13 T2D samples and controls, an 
initial view (PCoA breakdown of Bray-Curtis distances 
between samples in mOTU taxonomic composition 
space; online supplementary figure 2) reveals the Kazakh 
samples as clearly separable from European samples and 
from previously sequenced non-European microbiome 
datasets. While batch effects are a possibility in metage-
nomic analysis, the protocol of the present study was also 
used for the largest groups of European control samples 
(MetaHIT), suggesting these differences cannot be 
reduced solely to such artefacts.
Considering distinguishing taxonomic features of 
the Kazakh samples, many bacterial taxa are signifi-
cantly enriched or depleted in this dataset (figure 2). Of 
phyla showing significant (Mann-Whitney U test False 
Discovery Rate (Benjamini-Hochberg adjustment), MWU 
FDR <0.05) differences in abundance between Kazakh and 
other datasets, Actinobacteria, Proteobacteria, Firmicutes 
and Bacteroidetes were found in all Kazakh samples, with 
several others also commonly found (online supplemen-
tary table 1). At the genus level, abundance of Blautia, 
Bifidobacterium, Ruminococcus, Bacteroides, Eubacterium, 
Faecalibacterium, Prevotella, Streptococcus and Clostridium 
all exceeded 1% in all samples. This is consistent with 
results obtained in an earlier study where a composite 
analysis using 16S amplicon sequencing conventional 
microbiological techniques was undertaken of the gut 
microbiota of Kazakh women.22
Previously, a metagenomic reference gene catalogue 
generated from 263 human gut samples was described.23 
Metagenomic reads from the stool samples in this study 
were mapped to this catalogue using the same proce-
dure as there. Roughly 10% fewer reads on average can 
be mapped for each Kazakh sample (data not shown) 
than was the case for previously published sample sets. 
This suggests the possibility that the microbial diversity in 
Kazakh metagenomes is underexplored.
Analysing the composition of the gut microbiota of this 
cohort under the mOTU framework, we identify 22 such 
mOTUs (corresponding to species) that are core to the 
Kazakh microbiota in the sense that each were found in at 
least 90% of samples. These core operational taxonomic 
units (OTUs) primarily belonged to the genera Faecali-
bacterium, Bacteroides, Dorea, Collinsella, Oscillibacter, Rumi-
nococcus, Subdoligranulum, Coprococcus and Prevotella.
enterotype analysis
Projecting the Kazakh samples into enterotype15 compo-
nent space (showing also 278 Danish MetaHIT samples 
for comparison) reveals Kazakh samples to be signifi-
cantly (Fisher’s exact test p<5e-14) and strongly (OR 
7.24, 95% CI 4.09 to 13.12) skewed towards enterotype 2 
(Prevotella-rich), a skew that holds for both autumn and 
winter samples, both MetS cases and controls, and both 
placebo and synbiotic study subjects (figure 3, table 2). 
Seventy-one per cent of Kazakh samples belong to this 
enterotype. It should be noted that while the present 
cohort consists of both healthy controls and MetS 
subjects, the same rough distribution of cases to control 
also hold for the MetaHIT Danish cohort, which we show 
for comparison, suggesting this enterotype shift towards 
Prevotella is idiosyncratic to the Kazakh population rather 
than any feature of metabolic disease.
Table 1 Overview of demographic data of participants
Number of 
participants
Average age 
(years)
Sex (male/
female)
BMI autumn 
(male) (kg/m2)
BMI winter 
(male) (kg/m2)
BMI autumn 
(female) 
(kg/m2)
BMI winter 
(female) 
(kg/m2)
Total 84 50.39 30/54 27.9 27.8 26.8 26.7
Subjects receiving 
NAR: yoghurt 
containing six probiotic 
species, collagen, 
pectin and inulin
43 50.02 16/27 27.9 27.8 26.8 26.4
Subjects receiving 
controls: yoghurt 
without supplements
41 50.78 14/27 28.4 28.7 27.37 27.7
Subjects with MetS 58 49.03 24/34 29.1 29 29.1 29
Healthy controls 26 52.83 6/20 23 23.1 22.9 22.9
The table shows the basic study design. The 84 participants were sampled twice each for 168 samples in total. Of these, roughly half 
underwent synbiotic intervention with NAR. In parallel, roughly one-third of the study participants were metabolically healthy, with the 
remainder diagnosed with MetS. The table further shows basic demographics (age and sex) and BMI distribution at the different time points.
BMI, body mass index; MetS, metabolic syndrome.
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Comparing autumn and winter samples, enterotypes 
remain stable over time; samples from the same donor 
are significantly (permutation test p<3e-5) more likely to 
remain stable over time than would be expected under 
a null model. Thus, whatever the mechanism behind 
the enrichment of Prevotella-type gut microbiomes in the 
Kazakh cohort, it is unlikely to reflect seasonal dietary or 
lifestyle changes.
Gut microbiome correlates to Mets in the Kazakh cohort
Comparing MetS case samples to healthy controls 
reveals borderline significantly (MWU p<0.1) decreased 
Figure 3 Enterotyping analysis Kazakh samples fall mostly 
within the Prevotella-rich enterotype 2, compared with Danish 
MetaHIT samples. Scatterplot shows samples projected onto 
the first two driver dimensions of enterotype space, with solid 
markers for the novel Kazakh samples and hollow markers 
for 278 Danish MetaHIT samples. Colours signify enterotype 
clusters. Same-donor samples in autumn and winter are 
connected by lines. Error bar diagram shows 95% CI of 
OR for falling within each enterotype if samples are Kazakh 
rather than MetaHIT; the Kazakh samples are depleted for 
enterotypes 1 and 3 and enriched for enterotype 2. Pie charts 
show sample distribution across enterotypes in the two 
cohorts.
Table 2 Comparative analysis of the enterotype distribution
Enterotype Kazakh (%)
MetaHIT 
(%)
Kazakh 
(N)
MetaHIT 
(N)
Bacteroidetes-rich 6 27 5 74
Prevotella-rich 71 26 60 71
Firmicutes-rich 23 48 19 133
The table shows enterotype assignment counts for the novel 
Kazakh samples as well as Danish MetaHIT samples for 
comparisons, shown as sample counts (N) and as percentages 
(%).
Figure 2 Bacterial families significantly different in Kazakh 
metagenomes Heatmap view of significantly enriched/
depleted bacterial families in the Kazakh metagenomes 
compared with those from reference datasets. Each column 
represents a comparison of the Kazakh data with each other 
dataset, and each row represents one bacterial family where 
at least one country comparison was significant. Colour scale 
shows the degree of change, as the ratio of mean abundance 
across the datasets. Asterisk markers denote statistical 
significance (Benjamini-Hochberg (BH) FDR scores from 
MWU tests comparing abundances. FDR <0.1; *FDR <0.05; 
**FDR <0.01; ***FDR <0.001). FDR, False Discovery Rate; 
MWU, Mann-Whitney U test.
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Shannon taxonomic diversity and community evenness 
between MetS cases and controls (figure 4). Across partic-
ipants, the ratio of the bacterial phyla Firmicutes to Bacte-
roidetes (F/B ratio) ranges from 0.2 to 21. Several studies 
(see refs 24–26) have shown that such high ratios are char-
acteristic of healthy young adults and that they decrease 
with age. This trend was not seen in the present cohort. 
However, the F/B ratio was significantly reduced (MWU 
p=0.0353) in MetS samples than in healthy controls. 
Previous studies (ref 27) have reported higher F/B ratios 
in obese subjects; these divergent accounts would be 
reconciled if such a ratio reflects an obesigenic habitual 
diet rather than obesity itself, as the MetS patients in 
the present study also have lower nutrient intake than 
controls, likely reflecting compliance with advice from 
their physicians following diagnosis.
Further analysis of MetS case samples compared with 
healthy controls reveals significantly (MWU test, BH 
FDR <0.1) different abundances of some bacterial species 
as well as some bacterial gene functional modules. Most 
significant differences concern relatively poorly charac-
terised mOTUs, with the MetS microbiomes depleted of 
Bifidobacteria and some butyrate producers like Subdoli-
granulum, while enriched for Prevotella. For bacterial gene 
functional annotation the KEGG database was used.28 
Forty-four KEGG pathways exhibited significant differ-
ences in abundance between MetS and healthy control 
samples. Notably, MetS cases in this cohort are enriched 
in genes for lipopolysaccharide biosynthesis and depleted 
of various systems for transporting or using sugars. These 
functional and taxonomic changes are intercorrelated 
(figure 5) and may, again, either represent the disease 
pathology or else steps such as diet changes in order to 
treat it.
Since the definition of MetS relies in part on obesity, 
body mass index (BMI) of donors may arguably act as a 
confounding factor, in case such features are dependent 
on BMI. To test this scenario, this contrast test was 
repeated, instead checking significance with respect to 
whether a general linear model of each tested feature 
considering both MetS status and BMI performed better 
than one considering BMI only as a dependent variable in 
modelling abundance of each tested feature. No feature 
is significantly different in abundance between MetS 
and control samples under this measure, suggesting it 
is difficult to disentangle features unique to MetS from 
those distinct to obesity itself. Comparison of the features 
found to distinguish MetS cases from controls in the 
Kazakh samples are not found to distinguish MetS cases 
from controls in the MetaHIT cohort,20 suggesting it is 
likely that health and lifestyle factors, as well as severity 
of the phenotype, here confounds any true metagenomic 
signature of the MetS.
Concordance of diet and the gut microbiota
We detected no significant changes in the microbiome 
under synbiotic treatment compared with placebo, 
though treatment did improve clinical phenotype of 
MetS patients significantly (data not shown). An overview 
of clinical and laboratory data for the 84 participants is 
provided in table 3. Full medical data, including antibi-
otic use history, were also recorded, and diet at enrolment 
was assessed via FFQs. As participants completed FFQs at 
enrolment, we investigated whether gut microbial compo-
sition (at either time point) could be explained in part 
from this data. Absolute nutrient amounts per day were 
projected from the FFQ data, and the resulting profiles 
were correlated against gut abundance of different micro-
bial taxa. Few or no association were found at broader 
taxonomic levels, whereas at the level of microbial taxa 
(mOTUs), 17 (11 not yet well characterised) had signifi-
cant (Spearman FDR <0.05) associations to one or more 
nutrient categories. Because of the dense structure of the 
resulting network, we visualise it (figure 6) as a power 
graph29 wherein nodes are grouped together based on 
their shared relationship to other sets of nodes.
Most associations were negative, signifying how higher 
intake of of some foods is associated with reduced abun-
dance of some bacteria. 
Seen as a whole, these data suggest that multiple 
poorly characterised species, particularly Prevotellas, 
Firmicutes and Clostridiales, are reduced in abundance 
either from overall higher food intake, or specifically 
intake of fats and sugars. Only two associations were 
positive, namely those between the alcohol consumption 
cluster (M) and a Bifidobacterium mapped to B. catenu-
latum and B. pseudocatenulatum. While our data do not 
allow verification, one possible explanation is that many 
popular Kazakh alcoholic beverages are based on milk 
fermentations (eg, koumiss; see ref 30).
seasonal changes to the gut microbiota
No tested single microbiome feature was significantly 
different in gut abundance between corresponding 
summer and winter samples (paired MWU test, requiring 
Figure 4 The ratio of Firmicutes to Bacteroidetes (F/B) 
boxplot showing for the MetS and control samples the ratio 
of bacterial phyla Firmicutes to Bacteroidetes. This ratio is 
slightly but significantly (MWU p<0.0353) reduced in MetS 
cases compared with controls. MetS case samples also 
have significantly (MWU p<0.1) lower Shannon diversity and 
community evenness than control samples. MetS, metabolic 
syndrome; MWU, Mann-Whitney U test.
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BH FDR <0.1 for significance). However, a multivariate 
analysis (modelling Bray-Curtis intersample distances 
from sample metadata concordances, table 4, online 
supplementary figure 3) shows a significant effect of 
season (analysis of variance (ANOVA) FDR <0.008) as 
well as of MetS status (ANOVA FDR <6.3e-8), though not 
of synbiotic use.
Analysis of the Kazakh gut antibiotic resistome
During 2014, 88.2 million packages of antibiotics were 
sold in Kazakhstan, with an increase of 33.7% during that 
year. This intensive use suggests a potential risk of antibi-
otic resistance development in human-associated micro-
biomes. However, in the present study, overall antibiotic 
resistance potential23 of gut microbes was not significantly 
higher in Kazakh than European samples. Figure 7 shows 
an integrated view of the antibiotic resistome for Kazakh 
samples, separated into MetS case samples and controls, 
compared with those from other datasets. In brief, the 
relative abundance of known antibiotic resistance genes 
is comparatively low in the Kazakh samples (figure 7, 
left panel). However, the relative proportion of each 
gut community that consists of taxa, which are known 
to potentially carry resistance genes, is relatively high 
(figure 7, right panel).
DIsCussIOn
Studies of the gut metagenome is a promising field for 
personalised medicine and may provide a unique tool 
for treatment of a range of recalcitrant diseases. Since 
2005, several studies have been published characterising 
gut metagenomes from host populations in countries in 
Figure 5 A heatmap view of the mOTU and KEGG module MetS signature Heatmap view of significantly enriched/depleted 
bacterial taxa (mOTUs) and functional modules (KEGG) in Kazakh MetS samples compared with controls. Shown are all such 
taxa (horizontal axis) or modules (vertical axis) significantly (MWU FDR <0.1) different between cases and controls, along with 
their Spearman rho correlations, with significant (Spearman FDR <0.1) correlations marked through asterisk labels (+:p<0.1, 
*p<0.05, **p<0.01, ***p<0.001). FDR, False Discovery Rate; KEGG, Kyoto Encyclopedia  of Genes and Genomes; MetS, 
metabolic syndrome; mOTU, metagenomic Operational Taxonomic Unit; MWU, Mann-Whitney U test.
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Europe31, South East Asia,32–34 Africa35 and the Americas,36 
under normal and pathological conditions. Such work has 
also identified new biomarkers of disease and suggested 
new approaches to diagnostics and therapy.9 15 34 37–43 The 
present study represents the first deep-sequencing char-
acterisation of the gut metagenome of a Central Asian 
population, drawn from samples from inhabitants of 
Kazakhstan. We observe that the distribution of entero-
types is strongly unlike that of other datasets, and we iden-
tify bacterial taxonomic groups significantly enriched and 
depleted in Kazakh individuals, with some features like 
elevated Escherichia also shared with Russian, Mongolian 
and East Asian populations, despite technical platform 
differences between these studies.
Comparing the Kazakh metagenomes with published 
16S profiles of Mongolian gut microbiomes reveal both 
similar and distinctive features.44 All these are likewise 
found among the core constituents we identified in the 
Kazakh gut microbiota, with the exception of Subdoli-
granulum, previously identified as a potentially protective 
factor against T2D.45 Concerning East Asian microbi-
omes, studies have been made of the gut microbiomes 
of Koreans.34 Comparing those results with the present 
Kazakh dataset reveals substantially different dominant 
bacterial taxa. Representatives of genera Oscillibacter, 
Subdoligranulum and Fusobacterium were found in the gut 
microbiomes of Kazakhs, but only sporadically, whereas 
they were ubiquitous in Korean samples (referring to 
the reported analysis in ref 46). The genus Lachnospira, 
however, was not identified in any of the Kazakh samples 
studied in the present work but was common in Korean 
samples. Notably, Lachnospira commonly persists in the 
gastrointestinal tracts of pigs. The transfer to the human 
gut of bacteria colonising that of food animals (‘farm-
to-fork’) has been well documented.47 Whereas pork is 
a common ingredient in Korean cooking,46 it is largely 
absent from the Kazakh diet, which is also supported by 
the present FFQ data (data not shown).
Analysis of a Russian cohort using the SOLiD plat-
form37 revealed enterotype 1 (Bacteroidetes-rich) as rare 
in that population, and we here observe the same trend in 
Kazakh samples, suggesting common underlying factors. 
While broadly similar, the Russian microbiomes reported 
previously also differ from our present findings in the 
Kazakh microbiomes, as those exhibit relatively low Lacto-
bacillus abundance whereas the Kazakh do not.
In both healthy and MetS Kazakh samples, we frequently 
see multiple opportunistic members of the microbiota. 
Inspection of coprograms revealed Escherichia coli as the 
most prevalent coliform found in these samples. Similar 
presence of high fractions of E. coli were also reported 
in previous studies of Russian (SOLiD sequencing, some 
donors from regions adjacent to Kazakhstan) and Mongo-
lian (454 sequencing and qPCR) microbiomes,37 44 and 
can further be seen enriched in Chinese compared with 
European samples.45 It is possible that this high back-
ground level corresponds to some degree to antibiotic 
exposure, whether in medicine or food production, as 
Escherichia generally carry more antibiotic resistance 
genes than other members of the gut microbiota.45
Beyond characterisation of the gut metagenomes of 
healthy Kazakh individuals, we compared such samples 
Table 3 Overview of clinical and laboratory data of participants
Variables MetS Healthy
Number of samples Man, n=24 Woman, n=34 Man, n=6 Woman, n=20
BMI (kg/m2) 29.0±2.9 29.1±3.1 23.0±1.6 22.9±2.2
Waist circumference (cm) 99.5±8.4 91.2±11.2 89.5±15.6 76.8±9.7
Hip circumference (cm) 116.4±24.8 110.4±9.4 104.9±6.2 100.2±10.9
Stool frequency (ordinal scale, see legend) 1.81±0.4 1.97±0.5 2.0±0.6 2.15±0.5
Stool consistency (Bristol scale value) 3.43±1.2 3.05±1.2 4.4±1.5 4.08±0.5
Haemoglobin (g/L) 145±15.5 126±14.4 147.1±10.3 123±12.3
Glucose in blood (mmol/L) 5.4±0.5 5.25±0.9 5.8±0.8 4.9±0.3
Triglyceride (mmol/L) 1.82±1.03 1.42±0.69 1.26±0.5 0.96±0.2
Cholesterol (mmol/L) 4.89±0.9 5.12±0.9 5.1±1.6 4.5±0.9
HDL (mmol/L) 3.01±0.7 2.98±0.8 3.27±1.2 2.50±0.6
LDL (mmol/L) 0.98±0.2 1.30±0.5 1.24±0.4 1.39±0.5
Systolic BP (mm Hg) 125.6±15.9 126.7±20.7 118.3±13.2 107.7±10.3
Diastolic BP (mm Hg) 81.9±10.5 80.1±8.8 78.3±13.2 69.4±8.7
CRP (mg/L) 2.43±2.4 4.0±3.81 3.15±2.8 2.2±2.3
Immunoregulatory Index (ratio) 1.13±0.4 1.22±0.36 1.14±0.4 1.24±0.3
The table provides data of clinical and laboratory investigations (shown as mean±SD where defined) for all 84 participants at enrolment. Stool 
frequency is measured on an ordinal scale (1: 1–2 times/day, 2: daily, 3: every other day, 4: weekly, 5: less than weekly).
BMI, body mass index; BP, blood pressure; CRP, C reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MetS, 
metabolic syndrome.
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with those from MetS48 patients. Unlike most other such 
studies where an increased F/B ratio was found associated 
with obesity and MetS, we found a significantly (though 
weakly) reduced F/B ratio in MetS participants in the 
present cohort compared with controls. Likewise, while 
we found significant gut microbial species associations to 
MetS status, these do not replicate in a European cohort20 
and also cannot be effectively disentangled from associ-
ations with overweight or lifestyle changes undertaken 
by the participants in response to their condition. Taken 
together, this underscores the MetS as a complex disease 
where possibly multiple different dietary patterns all 
could contribute while having different effects on the gut 
microbiome, suggesting significant risks of confounding 
in such studies unless very carefully controlled for.
The traditional diet of Kazakhstan is very different 
from either European or East Asian cuisine. Most Kazakh 
individuals have a high intake of red meat (especially 
horse), black and/or green tea (average 6–10 cups a day), 
fermented milk products and large amounts of butter-
fried baked goods. We find distinct and significant effects 
of the diet of the study participants on the composition 
of their gut microbiomes, mostly on poorly characterised 
taxonomic groups. Further research on larger cohorts 
still, as well as thorough meta-analysis, will be required 
to fully chart these dependencies, including the extent 
to which they may underlie regional differences in micro-
biomes. If we can robustly understand dietary impact 
on the microbiome, we may become able to manipu-
late those ecosystems, and the health states they impact, 
Figure 6 Diet–microbiome associations in the Kazakh cohort power network visualisation of significant (Spearman test FDR 
<0.1) associations between dietary measurements and gut microbial composition (bacterial mOTU abundances). FDR, False 
Discovery Rate; mOTU, metagenomic Operational Taxonomic Unit. A central power node (A) containing subnodes for sugars (B 
and C) and fats (D) along with some minerals, as well as measures for overall energy consumption, likely represents total food 
intake, with an unclassified Clostridiales (family level assignment) being depleted as this measure rises. The mineral subcluster 
is anti-correlated with several unclassified Clostridia (class level assignment) (F), individually anticorrelated with clusters 
involving polysaccharides and minerals (G and H) and a cluster representing intake of fish, fruits and vegetables (I). Another 
cluster (J) of unclassified Firmicutes, the archaeon Methanobrevibacter smithii and an Alistipes, anticorrelated with consumption 
of nuts and seeds, with one unclassified Firmicute also anticorrelated to fat intake. Galactose intake was anticorrelated with 
abundance of two unclassified bacteria from families Oscillospiraceae and Lachnospiraceae (K), respectively. Overall sugar 
intake was anticorrelated with a cluster (L) involving several Prevotella, including Prevotella copri, Eubacterium biforme and an 
unclassified Bacteroidetes. P. copri show further anticorrelation with another sugar cluster (B) and a cluster containing fats, oils, 
lactose and milk products (N). 
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through dietary interventions.4 7 The present study was 
in part intended to test the effects on the microbiome 
of on one hand seasonal change (resulting in shifts in 
environmental factors, time spent indoors, and summer 
vs winter diet), and on the other hand, the effect of a 
synbiotic treatment based on traditional milk fermenta-
tions combined with prebiotics.
While this synbiotic was significantly associated with 
protection from and even reversal of a seasonally asso-
ciated increase in BMI common in Kazakhstan (data not 
Table 4 Taxonomic distance regression
ANOVA of a linear model regressing Bray-
Curtis intersample distances on donor, 
timepoint, disease status and treatment status 
concordance
Df
Sum of square 
deviations
Fraction of 
variance 
explained, % F-statistic Pr(>F)
Same/different donor 1 4.89 2.47 359.41 <2e-16
Same/different timepoint 1 0 0.00 0.02 0.9
Same/different MetS status 1 2.59 1.31 190.37 <2e-16
Same/different synbiotic status 1 0 0.00 0.2 0.65
Residuals 14 023 190.81 96.23
Sum 198.29 100.00
ANOVA of a linear model regressing Bray-Curtis intersample distances on donor, timepoint, disease status and treatment status concordance. 
Same-donor samples are significantly more similar to each other than to samples from other donors, reflecting individual-specific gut 
microbiota over time. Samples also are significantly more different if they are discordant for MetS status, whereas no such effect is found 
either for season of sampling or for placebo/synbiotic status.
ANOVA, analysis of variance; MetS, metabolic syndrome.
Figure 7 Comparative gut resistome analysis of the Kazakh cohort. The left panel shows as boxplots the relative fraction of 
DNA from gut microbiome samples, which encode known antibiotic resistance genes. These fractions reflect both taxonomic 
composition of the samples and any enrichment, which may be in place for antibiotic resistance genes, such as selective 
pressure from exposure. The right panel shows what fraction of DNA from each sample derives from bacteria assigned to 
taxa (at the level of species clusters) where there are genomes known to contain antibiotic resistance genes. CN, China; DK, 
Denmark; ES, Spain; KZ-CTRL, Healthy Kazakh; KZ-MetS, Metabolic Syndrome Kazakh; SE, Swedish; US, United States of 
America. 
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shown), metagenomic analysis revealed neither seasonal 
differences nor any difference between participants 
receiving synbiotic or placebo. Previously, meta-analysis 
has shown similar results, in that the use of probiotics/
synbiotics often does not lead to significant changes in 
diversity and richness of the gut microbiota.47 Given this 
finding on one hand of a significant change in host pheno-
type under synbiotic treatment, and on the other hand, no 
significant microbiome compositional changes associated 
with this difference, further studies clearly are needed 
into mode of action of such synbiotics. It is conceivable 
that either very strain-specific properties of the probiotic 
component plays a part, or else that the prebiotic compo-
nent affects the human host either directly or through 
effects on satiety and thus food consumption.
Concerning our observations of unexpectedly low 
extent of seasonal effects, Zhang et al44 reported similar 
results from a study of gut microbiome variation over 
the year in Mongolian participants: while rural partici-
pants exhibited clear seasonal gut microbiome changes, 
reflecting shifts in diet, no such effects were found in 
subjects from urban areas, suggesting that the absence of 
a clear seasonal signal here likewise may reflect the urban 
lifestyle of the participants. This highlights how further 
studies into the microbiome of Kazakh individuals might 
aim to contrast rural and urban populations.
Concerning our findings of no higher overall resis-
tance gene carriage in Kazakh samples compared with 
Western ones despite high sales of antibiotics, there are 
several ways to interpret these data. The Kazakh samples 
may as yet truly contain only low amounts of antibiotic 
resistance genes. Alternately, such genes may be present 
but sufficiently different from other such genes known 
and characterised elsewhere that they are not yet iden-
tified, suggesting functional metagenomic analysis for 
novel resistance genes may be fruitful. The relatively 
higher abundance of bacterial taxa, which can carry resis-
tance genes, even if such genes were not found here, 
may suggest that composition broadly has been affected 
by antibiotic exposure, though further analysis would be 
required to formally test this.
Our study has a number of limitations. First, partic-
ipants were all volunteers from the capital Astana, 
attached to the same hospital and occupying a similar 
social position. This is not a representative sample 
and may not reflect all persons across Kazakhstan 
and Central Asia more generally. Given that thus far 
genomes are unavailable for the probiotic strains used, 
it is possible that we fail to observe subtle metagenomic 
shifts involving carriage of these strains. Furthermore, 
the FFQs were filled only during participant enrolment, 
meaning that changes in diet during winter or following 
synbiotic treatment cannot be assessed directly. It is 
further possible that the study lacks statistical power to 
assess subtle changes in microbiomes more generally. 
Further research will be necessary to assess the impact 
of diet and environmental factors on the gut micro-
biota and its role in the development of lifestyle-related 
diseases, particularly as they may increase following 
the transition of societies from a traditional to a more 
modern lifestyle and diet.
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